Job · Gilead Sciences
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
| Employer | Gilead Sciences |
|---|---|
| Location | 3 Locations |
| Function | Operations |
| Seniority | Director |
| Posted | 14 Oct 2026 |
About the role
Gilead Sciences is hiring a Director, Global Value & Access Strategy (Cell-Therapy Autoimmune) to lead market access efforts for Kite's autoimmune cell therapy portfolio. The role involves developing global reimbursement strategies and collaborating with internal teams to integrate payer perspectives into clinical development and launch planning. Candidates require an advanced degree and significant experience in pharmaceutical market access, with a preference for background in autoimmune diseases and advanced therapies.
Summary written by GAR, Octum’s cognitive engine, from the employer’s posting. The full description is on the employer’s site.
More roles at Gilead Sciences
Collected by Octum from Gilead Sciences’s careers site on 3 Nov 2026; Octum is not the employer and does not take applications. Spotted something wrong? Tell us.